Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases

Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases

US Patent 8853251 · Granted Oct 7, 2014

Estimated economic value: $190,844,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of diagnosing and treating dry eye syndrome and compositions for treatin2025
Methods of diagnosing and treating dry eye syndrome and compositions for treatin2024
Sterilization device utilizing low intensity UV-C radiation and ozone2023
Methods of diagnosing and treating dry eye syndrome and compositions for treatin2023
Preparation method for fumaric acid pour point depressant for crude oil2022
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidaz2022
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidaz2022
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidaz2022
Presbyopia treatments2022
Phenyl urea derivatives as N-formyl peptide receptor modulators2022
3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof2021
Phenyl urea derivatives as n-formyl peptide receptor modulators2021